A. Pritchard

发表

Recurrent inactivating RASA2 mutations in melanoma

K. Dutton-Regester, Jimmy Lin, G. Mann, 2015, Nature Genetics.

Pan-cancer analysis of whole genomes

Steven J. M. Jones, Nuno A. Fonseca, Icgc, 2020, Nature.

Molecular Pathways: Mitogen-Activated Protein Kinase Pathway Mutations and Drug Resistance

N. Hayward, A. Pritchard, 2013, Clinical Cancer Research.

Intergenic disease-associated regions are abundant in novel transcripts

J. Mattick, R. Taft, A. Pritchard, 2017, Genome Biology.

POT1 loss-of-function variants predispose to familial melanoma

Thomas M. Keane, K. Brown, D. Bishop, 2014, Nature Genetics.

High Efficiency Ex Vivo Cloning of Antigen-Specific Human Effector T Cells

A. Pritchard, M. Neller, C. Schmidt, 2014, PloS one.

Role of Serotonin Transporter Polymorphisms in the Behavioural and Psychological Symptoms in Probable Alzheimer Disease Patients

C. Lendon, A. Pritchard, P. Bentham, 2007, Dementia and Geriatric Cognitive Disorders.

Alzheimer ' s disease ) gene with OLR 1 oxidised LDL receptor 1 (-UTR polymorphisms of the ′ Association of 3

S. DeKosky, F. Pasquier, D. Mann, 2003 .

Identifying neoantigens for use in immunotherapy

A. Pritchard, S. Hutchison, 2018, Mammalian Genome.

Evaluation of Immune Responses to Influenza Vaccination in Chronic Obstructive Pulmonary Disease

Julie G. Burel, J. Davies, A. Pritchard, 2013 .

The Clinical Utility of Epigenetics: A Case Study

M. A. Sloane, L. Hesson, A. Pritchard, 2019, Clinical Epigenetics.

The plasmacytoid dendritic cell: at the cross-roads in asthma

A. Pritchard, S. Phipps, J. Upham, 2013, European Respiratory Journal.

Systematic review and meta‐analysis of genomic alterations in acral melanoma

N. Hayward, P. Johansson, A. Pritchard, 2022, Pigment cell & melanoma research.

Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families.

S. Puig, D. Bishop, D. Elder, 2017, The Journal of investigative dermatology.

A B‐cell or a key player? The different roles of B‐cells and antibodies in melanoma

A. Pritchard, C. Mustard, S. Hutchison, 2022, Pigment cell & melanoma research.

The deacylase SIRT5 supports melanoma viability by regulating chromatin dynamics

Erika L. Varner, M. Rivera, Ho-Joon Lee, 2020, bioRxiv.

Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers

N. Hayward, P. Johansson, A. Pritchard, 2018, PloS one.

Loss-of-function variants in POT1 predispose to uveal melanoma

H. Pickett, N. Hayward, P. Johansson, 2020, Journal of Medical Genetics.

Association study and meta-analysis of low-density lipoprotein receptor related protein in Alzheimer's disease

D. Clair, J. Lambert, C. Lendon, 2005, Neuroscience Letters.

Sensitive droplet digital PCR method for detection of TERT promoter mutations in cell free DNA from patients with metastatic melanoma

N. Hayward, A. Pritchard, M. Millward, 2017, Oncotarget.

UHI Research Database pdf download summary Sensitive droplet digital PCR method for detection of TERT promoter mutations in cell free DNA from patients with metastatic melanoma McEvoy,

N. Hayward, A. Pritchard, M. Millward, 2017 .

Adaptive immunity to rhinoviruses: sex and age matter

J. Davies, A. Pritchard, J. Upham, 2010, Respiratory research.

Database pdf download summary Targeting Neoantigens for Personalised Immunotherapy

A. Pritchard, 2019 .

Targeting Neoantigens for Personalised Immunotherapy

A. Pritchard, 2018, BioDrugs.

No association between neuregulin 1 and psychotic symptoms in Alzheimer's disease patients.

R. Holder, C. Lendon, A. Pritchard, 2010, Journal of Alzheimer's disease : JAD.

No association between polymorphisms in the lectin-like oxidised low density lipoprotein receptor (ORL1) gene on chromosome 12 and Alzheimer’s disease in a UK cohort

D. Clair, D. Mann, C. Lendon, 2004, Neuroscience Letters.

FRAMe: Familial Risk Assessment of Melanoma—a risk prediction tool to guide CDKN2A germline mutation testing in Australian familial melanoma

G. Mann, N. Hayward, A. Pritchard, 2020, Familial cancer.

A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma

K. Brown, J. Trent, N. Hayward, 2015, Clinical genetics.

Innate IFNs and Plasmacytoid Dendritic Cells Constrain Th2 Cytokine Responses to Rhinovirus: A Regulatory Mechanism with Relevance to Asthma

Julie G. Burel, A. Pritchard, S. Phipps, 2012, The Journal of Immunology.

Relevance to Asthma Rhinovirus: A Regulatory Mechanism with Cells Constrain Th2 Cytokine Responses to Innate IFNs and Plasmacytoid Dendritic

Julie G. Burel, A. Pritchard, S. Phipps, 2012 .

Innate interferons inhibit allergen and microbial specific TH2 responses

Julie G. Burel, A. Pritchard, J. Upham, 2012, Immunology and cell biology.

Interleukin-6 promoter polymorphism: risk and pathology of Alzheimer's disease

D. Clair, D. Mann, J. Lambert, 2004, Neuroscience Letters.

Clinical factors associated with the humoral immune response to influenza vaccination in chronic obstructive pulmonary disease

Julie G. Burel, J. Davies, A. Pritchard, 2013, International journal of chronic obstructive pulmonary disease.

Mutation load in melanoma is affected by MC1R genotype

J. Pearson, G. Mann, N. Hayward, 2017, Pigment cell & melanoma research.

Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma.

Thomas M. Keane, K. Brown, J. Trent, 2015, Journal of the National Cancer Institute.

The effect of the apolipoprotein E gene polymorphisms and haplotypes on behavioural and psychological symptoms in probable Alzheimer’s disease

R. Holder, C. Lendon, A. Pritchard, 2006, Journal of Neurology, Neurosurgery & Psychiatry.

Investigation of dopamine receptors in susceptibility to behavioural and psychological symptoms in Alzheimer's disease

R. Holder, C. Lendon, A. Pritchard, 2009, International journal of geriatric psychiatry.

Role of 5HT2A and 5HT2C polymorphisms in behavioural and psychological symptoms of Alzheimer's disease

R. Holder, C. Lendon, A. Pritchard, 2008, Neurobiology of Aging.

Role of 5HT 2A and 5HT 2C polymorphisms in behavioural and psychological symptoms of Alzheimer's disease.

R. Holder, C. Lendon, A. Pritchard, 2008, Neurobiology of aging.

Genetic variation of the APOE promoter and outcome after head injury

C. Lendon, A. Pritchard, G. Murray, 2003, Neurology.

Germline variants in oculocutaneous albinism genes and predisposition to familial cutaneous melanoma

N. Hayward, P. Johansson, A. Pritchard, 2019, Pigment cell & melanoma research.

FRAMe: Familial Risk Assessment of Melanoma—a risk prediction tool to guide CDKN2A germline mutation testing in Australian familial melanoma

G. Mann, N. Hayward, A. Pritchard, 2020, Familial Cancer.

Whole-genome landscapes of major melanoma subtypes

Catherine A. Shang, J. Pearson, H. Pickett, 2017, Nature.

Genetics of familial melanoma: 20 years after CDKN2A

N. Hayward, A. Pritchard, K. Wadt, 2015, Pigment cell & melanoma research.

Genetics and Epigenetics: A Historical Overview

L. Hesson, A. Pritchard, 2019, Clinical Epigenetics.

Patterns of somatic structural variation in human cancer genomes

Nuno A. Fonseca, Gary D Bader, Benjamin J. Raphael, 2020, Nature.

Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours

J. Pearson, G. Mann, N. Hayward, 2020, Nature Communications.

Prolonged stable disease in a uveal melanoma patient with germline MBD4 nonsense mutation treated with pembrolizumab and ipilimumab

N. Hayward, P. Johansson, A. Pritchard, 2019, Immunogenetics.

Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

Nuno A. Fonseca, Gary D Bader, Benjamin J. Raphael, 2020, Nature Communications.

The deacylase SIRT5 supports melanoma viability by influencing chromatin dynamics.

Erika L. Varner, M. Rivera, Ho-Joon Lee, 2021, The Journal of clinical investigation.

Molecular Pathways Molecular Pathways : Mitogen-Activated Protein Kinase Pathway Mutations and Drug Resistance

N. Hayward, A. Pritchard, 2013 .

Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System

A. Pritchard, I. Megson, S. MacRury, 2021, Frontiers in Cardiovascular Medicine.

G9a Inhibition Enhances Checkpoint Inhibitor Blockade Response in Melanoma

N. Hayward, F. Gannon, J. Wilmott, 2021, Clinical Cancer Research.

Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide

Ivana K. Kim, S. Puig, N. Hayward, 2018, Journal of the National Cancer Institute.

Meta-Analysis and Systematic Review of the Genomics of Mucosal Melanoma

N. Hayward, P. Johansson, A. Pritchard, 2021, Molecular Cancer Research.

The Role of Histone Variants in Cancer

A. Pritchard, 2019, Clinical Epigenetics.

Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility

J. Pearson, K. Shannon, G. Mann, 2018, International journal of cancer.

Exploration of peptides bound to MHC class I molecules in melanoma

N. Hayward, A. Pritchard, M. Neller, 2015, Pigment cell & melanoma research.

BRAF/NRAS wild-type melanoma, NF1 status and sensitivity to trametinib

K. Dutton-Regester, N. Hayward, D. Adams, 2014, Pigment cell & melanoma research.

POLE mutations in families predisposed to cutaneous melanoma

Nicholas G. Martin, Ian Tomlinson, Grant W. Montgomery, 2015, Familial Cancer.

Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma.

K. Brown, G. Mann, N. Hayward, 2019, Melanoma research.

Exome Sequencing to Predict Neoantigens in Melanoma

Julie G. Burel, Christopher W. Schmidt, N. Hayward, 2015, Cancer Immunology Research.

Recurrent inactivating RASA 2 mutations in melanoma

K. Dutton-Regester, Jimmy Lin, G. Mann, 2022 .

Multiplex melanoma families are enriched for polygenic risk

M. Iles, D. Duffy, N. Martin, 2020, Human Molecular Genetics.

A polymorphic variation in the interleukin 1A gene increases brain microglial cell activity in Alzheimer’s disease

E. Green, D. Mann, J. Lambert, 2004, Journal of Neurology, Neurosurgery & Psychiatry.

Genetic associations between cathepsin D exon 2 C→T polymorphism and Alzheimer’s disease, and pathological correlations with genotype

D. Neary, D. Mann, C. Lendon, 2006, Journal of Neurology, Neurosurgery & Psychiatry.

Bone marrow transplantation generates T cell–dependent control of myeloma in mice

Thomas S. Watkins, N. Waddell, P. Johansson, 2018, The Journal of clinical investigation.

The Role of 5-HT 2C Polymorphisms in Behavioral and Psychological Symptoms of Alzheimer Disease

A. Pritchard, 2011 .

Investigation of the Role of the Dopamine Transporter in Susceptibility to Behavioural and Psychological Symptoms of Patients with Probable Alzheimer’s Disease

C. Lendon, A. Pritchard, P. Bentham, 2008, Dementia and Geriatric Cognitive Disorders.

Immune signatures in cutaneous melanoma correlate with survival independently of immunotherapy treatment

N. Hayward, P. Johansson, A. Pritchard, 2023, Pigment cell & melanoma research.

A rare missense variant in protection of telomeres 1 (POT1) predisposes to a range of haematological malignancies

N. Hayward, P. Johansson, A. Pritchard, 2020, British journal of haematology.

Comprehensive molecular characterization of mitochondrial genomes in human cancers

Nuno A. Fonseca, Gary D Bader, Benjamin J. Raphael, 2017, bioRxiv.

A 3’-UTR polymorphism in the oxidized LDL receptor 1 gene increases Aβ40 load as cerebral amyloid angiopathy in Alzheimer’s disease

D. Mann, J. Lambert, C. Lendon, 2005, Acta Neuropathologica.

Association of 3′-UTR polymorphisms of the oxidised LDL receptor 1 (OLR1) gene with Alzheimer’s disease

S. DeKosky, F. Pasquier, D. Mann, 2003, Journal of medical genetics.

Author Correction: Pan-cancer analysis of whole genomes

Nuno A. Fonseca, Gary D Bader, Benjamin J. Raphael, 2023, Nature.

A screen for combination therapies in BRAF/NRAS wild type melanoma identifies nilotinib plus MEK inhibitor as a synergistic combination

Anton J. Enright, A. Speak, G. Bignell, 2017, bioRxiv.

Candidate gene association studies of the alpha 4 (CHRNA4) and beta 2 (CHRNB2) neuronal nicotinic acetylcholine receptor subunit genes in Alzheimer's disease.

Carol Brayne, Simon Lovestone, Sarah Walter, 2004, Neuroscience letters.

Sex differences in oncogenic mutational processes

Nuno A. Fonseca, Gary D Bader, Benjamin J. Raphael, 2019, Nature Communications.

Correction to: Prolonged stable disease in a uveal melanoma patient with germline MBD4 nonsense mutation treated with pembrolizumab and ipilimumab

N. Hayward, P. Johansson, A. Pritchard, 2019, Immunogenetics.

Correction to: Prolonged stable disease in a uveal melanoma patient with germline MBD4 nonsense mutation treated with pembrolizumab and ipilimumab

N. Hayward, P. Johansson, A. Pritchard, 2019, Immunogenetics.

Estimating CDKN2A mutation carrier probability among global familial melanoma cases using GenoMELPREDICT.

S. Puig, D. Bishop, D. Elder, 2019, Journal of the American Academy of Dermatology.

Apolipoprotein E ε4 Allele Frequency and Age at Onset of Alzheimer’s Disease

D. Neary, D. Mann, A. Burns, 2006, Dementia and Geriatric Cognitive Disorders.

Microsimulation Model for Evaluating the Cost-Effectiveness of Surveillance in BAP1 Pathogenic Variant Carriers.

N. Hayward, P. Johansson, A. Pritchard, 2021, JCO clinical cancer informatics.

Germline Variants in Childhood Cutaneous Melanoma.

N. Hayward, P. Johansson, A. Pritchard, 2023, The Journal of investigative dermatology.

Medical and surgical care of mesothelioma patients and their relatives carrying germline BAP1 mutations.

Chuong D. Hoang, V. Rusch, S. Pastorino, 2022, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Asthma Is Associated with Multiple Alterations in Anti-Viral Innate Signalling Pathways

Simon Phipps, Julie G. Burel, A. Pritchard, 2014, PloS one.

Novel high risk genes of melanoma

N. Hayward, D. Adams, P. Johansson, 2017 .

Systematic review and meta-analysis of genomic alterations in acral melanoma

N. Hayward, P. Johansson, A. Pritchard, 2022 .

Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes

J. Pearson, K. Shannon, N. Hayward, 2022, Cancer discovery.

A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns

Nuno A. Fonseca, Benjamin J. Raphael, Allison P. Heath, 2020, Nature Communications.